cholecystokinin ; Rattus norvegicus






1667 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 165714 Effects of gastrointestinal hormones on vascular smooth muscle. Am J Dig Dis 1975 Apr 1
2 168355 Pancreatic acinar cells: effect of acetylcholine, pancreozymin, gastrin and secretin on membrane potential and resistance in vivo and in vitro. J Physiol 1975 May 1
3 226515 Preparation of biologically active radioiodinated cholecystokinin for radioreceptor assay and radioimmunoassay. J Biol Chem 1979 Oct 10 5
4 263547 Specificity of cholecystokinin satiety effect: reduction of food but not water intake. Pharmacol Biochem Behav 1977 Jun 3
5 341386 Effect of a synthetic analogue of PGE2 on exocrine and endocrine pancreatic function in the rat. Surgery 1978 Feb 2
6 343601 Effect of chronic pentagastrin, cholecystokinin, and secretin on pancreas of rats. Am J Physiol 1978 Mar 6
7 404865 Cholecystokinin and satiety in rats and rhesus monkeys. Am J Clin Nutr 1977 May 1
8 500815 Brain cholecystokinin and nutritional status in rats and mice. J Clin Invest 1979 Nov 1
9 519526 Effect of cholecystokinin, secretin, and gastric inhibitory polypeptide on insulin release from the isolated perfused rat pancreas. Can J Physiol Pharmacol 1979 Nov 1
10 690290 Effect of cholecystokinin on meal size and intermeal interval in the sham-feeding rat. J Comp Physiol Psychol 1978 Aug 1
11 727996 The effect of cycloheximide on cholecystokinin-evoked pancreatic juice of the anaesthetized rat. Aust J Exp Biol Med Sci 1978 Aug 2
12 986152 [14C]leucine incorporation into proteins of pancreatic juice in rats fed soya-bean flour. Br J Nutr 1976 Sep 1
13 1206529 Secretion of electrolytes by the pancreas of the anaestetized rat. J Physiol 1975 Nov 2
14 1245285 Effect of cholecystokinin and 16,16-dimethyl prostaglandin E2 on RNA and DNA of gastric and duodenal mucosa. Gastroenterology 1976 Jan 2
15 1280937 The cortical lesion of Huntington's disease: further neurochemical characterization, and reproduction of some of the histological and neurochemical features by N-methyl-D-aspartate lesions of rat cortex. Ann Neurol 1992 Oct 1
16 1282297 Effects of okadaic acid indicate a role for dephosphorylation in pancreatic stimulus-secretion coupling. Am J Physiol 1992 Dec 5
17 1282765 Short-term restraint stress and s.c. saline injection alter the tissue levels of substance P and cholecystokinin in the peri-aqueductal grey and limbic regions of rat brain. Acta Physiol Scand 1992 Nov 2
18 1283533 Accelerated expression of cholecystokinin gene in the brain of rats rendered tolerant to morphine. Neuroreport 1992 Dec 6
19 1283979 Effects of calmodulin inhibitors on amylase secretion from rat pancreatic acini. Digestion 1992 2
20 1301645 [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents]. Therapie 1992 Nov 5
21 1302281 Depolarizing action of cholecystokinin on rat supraoptic neurones in vitro. J Physiol 1992 Dec 2
22 1312208 Dopaminergic regulation of cholecystokinin mRNA content in rat striatum. Brain Res Mol Brain Res 1992 Jan 12
23 1330214 GABA, acting at both GABAA and GABAB receptors, inhibits the release of cholecystokinin-like material from the rat spinal cord in vitro. Brain Res 1992 Sep 11 3
24 1334505 Trigeminal and dorsal root ganglion neurons express CCK receptor binding sites in the rat, rabbit, and monkey: possible site of opiate-CCK analgesic interactions. J Neurosci 1992 Dec 3
25 1340061 The biochemical characterization of the native pancreatic cholecystokinin receptor using affinity labeling approaches. Yale J Biol Med 1992 Sep-Oct 2
26 1346163 Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor. J Pharmacol Exp Ther 1992 Jan 10
27 1354999 Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission. Brain Res 1992 Apr 24 5
28 1357976 Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats. Am J Physiol 1992 Sep 5
29 1359571 Evaluation of a stable CCK agonist (A68552) in conditioned avoidance responding in mice, rats, and primates: comparison with typical and atypical antipsychotics. Pharmacol Biochem Behav 1992 Oct 2
30 1360313 Mechanisms of cholecystokinin-induced protection of cultured cortical neurons against N-methyl-D-aspartate receptor-mediated glutamate cytotoxicity. Brain Res 1992 Oct 2 6
31 1360636 Pre-synaptic dopaminergic control mechanisms for CCK-8 like immunoreactivity in the rat medial frontal cortex. Neuropeptides 1992 Oct 12
32 1364831 Pharmacology of a cholecystokinin receptor on 5-hydroxytryptamine neurones in the dorsal raphe of the rat brain. Br J Pharmacol 1991 Mar 1
33 1371709 Effect of neonatal capsaicin treatment on cholecystokinin-(CCK8) satiety and axonal transport of CCK binding sites in the rat vagus nerve. Brain Res 1992 Jan 13 6
34 1372739 Effects of FK506 on exocrine pancreas in rats. Pancreas 1992 2
35 1373568 Role of cholecystokinin in induction and maintenance of dietary protein-stimulated pancreatic growth. Am J Physiol 1992 Apr 1
36 1375937 CCK-JMV-180, an analog of cholecystokinin, releases intracellular calcium from an inositol trisphosphate-independent pool in rat pancreatic acini. J Biol Chem 1992 Jun 5 4
37 1376278 Substance P-, vasoactive intestinal polypeptide-, and cholecystokinin-like immunoreactive fiber projections from the superior colliculus to the dorsal lateral geniculate nucleus in the rat. Exp Brain Res 1992 1
38 1379497 Biochemical characterization of particles from rat striatum containing dopamine, cholecystokinin or both. Arch Int Physiol Biochim Biophys 1992 Mar-Apr 2
39 1379547 Monitor peptide gene expression is increased by exogenous CCK in the rat pancreas and in a rat pancreatic acinar cell line (AR4-2J). FEBS Lett 1992 Aug 3 1
40 1380304 Endothelin increases [Ca2+]i in rat pancreatic acinar cells by intracellular release but fails to increase amylase secretion. Biochim Biophys Acta 1992 Aug 12 1
41 1381750 Role of cyclic nucleotides and calcium in the nutrient-induced release of cholecystokinin-like immunoreactivity in rats. J Physiol 1992 Apr 12
42 1385171 Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia. Eur J Pharmacol 1992 Aug 25 2
43 1385345 Structure activity of C-terminal modified analogs of Ac-CCK-7. Int J Pept Protein Res 1992 Apr 8
44 1393262 Functional comparisons of gastrin/cholecystokinin receptors in isolated preparations of gastric mucosa and ileum. Br J Pharmacol 1992 Jun 8
45 1394834 Azaserine-induced pancreatic foci: detection, growth, labelling index and response to raw soya flour. Carcinogenesis 1992 Sep 1
46 1394835 Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide. Carcinogenesis 1992 Sep 5
47 1396996 Release of immunoreactive [Met5]enkephalin and cholecystokinin from the spinal cord by beta-endorphin administered intraventricularly in the pentobarbital-anesthetized rat. Eur J Pharmacol 1992 May 14 1
48 1403798 Regulation of cholecystokinin mRNA content in rat striatum: a glutamatergic hypothesis. J Pharmacol Exp Ther 1992 Oct 4
49 1407694 Effect of the 5-HT3 receptor antagonist ondansetron on hypothalamic self-stimulation in rats and its interaction with the CCK analogue caerulein. Neurosci Lett 1992 Jun 8 3
50 1411279 Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide. Scand J Gastroenterol 1992 Sep 2